Medicare provides health coverage to over 60 million older adults and people with disabilities, paying for important medical care in hospital and outpatient settings. Nearly 12.5 million beneficiaries also rely on Medicaid, which helps with affordability through the Medicare Savings Programs (MSPs), and covers services Medicare does not, such as long-term services and supports. The Medicare Rights Center supports strengthening Medicare and Medicaid, modernizing benefits and financial assistance, and bolstering the workers and caregivers who deliver this vital care.
It has been two years since the passage of the Inflation Reduction Act of 2022 (IRA). The landmark legislation included
In late April, the U.S. Department of Health and Human Services (HHS) updated regulations for Section 1557 of the Affordable Care
In 2023, the Centers for Medicare & Medicaid Services (CMS) opened a review to determine if Medicare should cover Preexposure
Last week, CMS released additional guidance regarding Medicare Prescription Payment Plan (MPPP) outreach and education. The MPPP, sometimes referred to
A new whitepaper from the Brookings Center on Health Policy draws on an array of data sources to identify opportunities
Late last month, the U.S. House Committee on Ways and Means advanced several bipartisan bills intended to reduce Medicare coverage
On June 27, the U.S. House Committee on Ways and Means advanced several bipartisan bills intended to improve Medicare coverage and affordability. While Medicare Rights applauds this important goal, we are concerned that several of the bills run counter to it. As outlined in the letter, we urged lawmakers to correct those misalignments.
The Inflation Reduction Act (IRA) of 2022 made key changes in Medicare law and coverage to improve prescription drug affordability for older adults and people with disabilities. Since its passage, some stakeholders and lawmakers have targeted IRA policies for revision or repeal, especially the law’s Medicare Drug Price Negotiation Program. Depending on the provisions targeted, this would increase beneficiary costs and increase Medicare spending.
It has been two years since the passage of the Inflation Reduction Act of 2022 (IRA). The landmark legislation included
In late April, the U.S. Department of Health and Human Services (HHS) updated regulations for Section 1557 of the Affordable Care
In 2023, the Centers for Medicare & Medicaid Services (CMS) opened a review to determine if Medicare should cover Preexposure
Last week, CMS released additional guidance regarding Medicare Prescription Payment Plan (MPPP) outreach and education. The MPPP, sometimes referred to
A new whitepaper from the Brookings Center on Health Policy draws on an array of data sources to identify opportunities
Late last month, the U.S. House Committee on Ways and Means advanced several bipartisan bills intended to reduce Medicare coverage
On June 27, the U.S. House Committee on Ways and Means advanced several bipartisan bills intended to improve Medicare coverage and affordability. While Medicare Rights applauds this important goal, we are concerned that several of the bills run counter to it. As outlined in the letter, we urged lawmakers to correct those misalignments.
The Inflation Reduction Act (IRA) of 2022 made key changes in Medicare law and coverage to improve prescription drug affordability for older adults and people with disabilities. Since its passage, some stakeholders and lawmakers have targeted IRA policies for revision or repeal, especially the law’s Medicare Drug Price Negotiation Program. Depending on the provisions targeted, this would increase beneficiary costs and increase Medicare spending.
